Striking a Delicate Balance: Disease Control Without Neurotoxicity.

[1]  R. Tsang,et al.  The Challenges of Applying Radiation in Primary Central Nervous System Lymphoma. , 2020, International Journal of Radiation Oncology, Biology, Physics.

[2]  D. Correa,et al.  Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Finkelstein,et al.  Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.